Morning Overview on MSN
The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans
Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get. The FDA approved gadoquatrane, a new gadolinium-based contrast agent designed ...
Rising chronic disease prevalence, safer contrast formulations and expanding diagnostic imaging capacity are supporting global market growth. Magnetic Resonance Imaging (MRI) Contrast Agents Market ...
Bracco Imaging, a global leader in diagnostic imaging, today announced the commercial availability of VUEWAY® injection (gadopiclenol), which received approval in September 2025 from the Federal ...
After decades of dormancy, deuterium is surging in research use as a contrast agent for MRI. Researchers discussed deuterium’s potential in a talk at the International Society for Magnetic Resonance ...
Nanoscientists have demonstrated a method for loading nanoparticles with iron ions to create MRI contrast agents that outperform gadolinium chelates, the mainstay contrast agent that is facing ...
Brain MRI without contrast agent is just as effective as the contrast-enhanced approach for monitoring disease progression in patients with multiple sclerosis (MS), according to a new study in the ...
You can keep your best guesses. Engineers at Rice University's George R. Brown School of Engineering are starting to understand exactly what goes on when doctors pump contrast agents into your body ...
MRI preparation depends on the type of scan, the area of your body being scanned, and whether the scan requires contrast dye. It’s important to discuss prep with your doctor beforehand. In rare, ...
Simulations reveal details about the magnetic interactions between gadolinium contrast agents used in MRI scans and their environment. You can keep your best guesses. Engineers at Rice University's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results